Investing.com - Financial Markets Worldwide

Guardant Health stock reaches 52-week high at 59.25 USD

Published 14/08/2025, 15:24
Guardant Health stock reaches 52-week high at 59.25 USD
GH
1.53%

Guardant Health Inc. stock reached a new 52-week high, closing at 59.25 USD. According to InvestingPro data, technical indicators suggest the stock is in overbought territory, with the company now commanding a market capitalization of $7.34 billion. This milestone reflects a significant upward trend for the company, which has seen its stock price increase by an impressive 106.17% over the past year. The company’s strong financial position is evidenced by a healthy current ratio of 3.71, while maintaining robust revenue growth of nearly 29% year-over-year. The surge in stock value underscores investor confidence and interest in Guardant Health’s offerings and market position. This 52-week high indicates a strong performance relative to the company’s stock price fluctuations over the past year, highlighting its resilience and growth potential in the competitive healthcare and biotechnology sectors. For deeper insights into Guardant Health’s technical indicators and comprehensive analysis, explore the detailed Pro Research Report available on InvestingPro.

In other recent news, Guardant Health reported impressive second-quarter results for 2025, surpassing market expectations. The company’s earnings per share (EPS) came in at -$0.44, significantly better than the forecasted -$0.72, representing a 38.89% surprise. Revenue also exceeded projections, reaching $232.1 million against the anticipated $211.27 million, marking a 9.86% revenue surprise. As a result of these strong financial performances, Guardant Health management raised their full-year revenue guidance to a growth of 24-25% year-over-year, up from the initial projection of 15-16%. Following these developments, Scotiabank increased its price target for Guardant Health from $57.00 to $60.00, maintaining a Sector Outperform rating. These adjustments reflect the company’s robust financial health and future growth prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.